PulseNmore
PulseNmore is an Israel-based digital health company developing FDA-authorized connected home ultrasound devices for prenatal and IVF monitoring, serving expectant mothers, fertility patients, obstetricians, and health systems via a smartphone-connected handheld cradle, mobile app, and clinician dashboard.
- Company typePublic
- Founded2014
- HeadquartersTel Aviv, Israel
- Headcount51–100
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What PulseNmore does
PulseNmore Ltd. is an Israel-based digital health company (publicly listed on Nasdaq and TASE under PLSM) that develops connected home ultrasound technology for prenatal and fertility care. Its platform combines a handheld ultrasound transducer cradle (260g, B-mode and M-mode at 2-5 MHz, up to 27cm depth, 1080p resolution) that connects to the patient's personal smartphone, a patient-facing mobile application (iOS and Android) supporting both app-guided and real-time clinician-guided teleultrasound workflows, and a web-based clinician dashboard with EMR integration. The company markets two core products: Pulsenmore ES, an FDA De Novo-authorized home-use prenatal ultrasound platform for fetal well-being assessment from week 14 of pregnancy, and Pulsenmore FC, an at-home follicular monitoring solution for IVF and fertility preservation cycles.
PulseNmore serves expectant mothers, fertility/IVF patients, obstetricians, maternal-fetal medicine specialists, and health systems, with named anchor customers including Clalit Health Services (Israel's largest HMO, ~5 million members), Sheba Medical Center's Sheba Beyond virtual hospital, Beilinson NEXT virtual hospital, Ouma Health (U.S. virtual maternity care), and U.S. practices TLC Perinatal PA and the Center for Fetal Medicine & Women's Ultrasound. Revenue is generated through a combination of hardware device sales (single-patient, one-pregnancy use cradle), subscription/recurring service contracts (e.g., $4.5M five-year Clalit FC agreement, 25,000-unit Clalit ES supply commitment), and strategic partnership economics anchored by GE Healthcare's $50 million investment with distribution rights. Distribution combines direct enterprise sales to health systems and providers, a consumer-facing shop.pulsenmore.com storefront requiring physician prescription, and channel partners/distributors across the U.S., EU, UK, Switzerland, Australia, Brazil, Colombia, and Israel.
PulseNmore firmographics
Firmographics- Name
- PulseNmore
- Legal name
- Pulsenmore Ltd.
- Website
- https://pulsenmore.com
- Company type
- Public
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- PulseNmore is an Israel-based digital health company developing FDA-authorized connected home ultrasound devices for prenatal and IVF monitoring, serving expectant mothers, fertility patients, obstetricians, and health systems via a smartphone-connected handheld cradle, mobile app, and clinician dashboard.
- Ownership category
- akta.pro rank
PulseNmore industry classification
Industry- Product category
- Home Prenatal Ultrasound Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Home Health Care Services (62161), Diagnostic Imaging Centers (621512)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring) (HLALAHAC)
- akta.pro secondary industries
- Maternal & Neonatal Remote Monitoring Platforms (HLACAFAC), Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables) (HLAHACAF), Maternal, Neonatal & Pediatric Remote Monitoring (HLACAPAG), Ultrasound & Echography Systems (HLAHABAD)
Keywords
Where PulseNmore is headquartered
LocationHeadquarters
- HQ city
- Tel Aviv
- HQ country
- Israel
- HQ region
- Middle East
Offices4 records
Markets served
PulseNmore business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Hardware Device Sales: Sale of Pulsenmore ES home ultrasound devices. Single patient, one pregnancy use device.
- Subscription/Service Platform: Ongoing service fees for cloud platform access, clinician dashboard, scan interpretation services, and technical support. $4.5M contract with Clalit over 5 years for Pulsenmore FC follicular monitoring service.
- Strategic Investment: GE Healthcare invested $50 million to support product approval and market expansion, including distribution rights in key markets.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Prescription-based device purchase through authorized providers |
| Subscription | Multi-year contract | Enterprise healthcare organization agreements |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
PulseNmore product offering
Product offeringCore offering
PulseNmore develops and sells connected home ultrasound hardware devices that pair with a patient's smartphone via a mobile app, enabling expectant mothers to perform guided ultrasound scans at home. The company offers two core products: Pulsenmore ES for prenatal fetal well-being assessment from week 14 and Pulsenmore FC for at-home follicular monitoring in IVF and fertility preservation. Scans are transmitted to a cloud-based clinician dashboard for remote physician interpretation, with a physician-supervised model that includes both app-guided and real-time clinician-guided scanning modes.
Product overview
PulseNmore is a digital prenatal care platform providing connected home ultrasound technology. The company offers two core products: Pulsenmore ES (Early Screening) for home prenatal ultrasound monitoring and Pulsenmore FC (Follicular Monitoring) for at-home IVF and fertility monitoring. The system architecture consists of a handheld ultrasound device/cradle that attaches to the patient's smartphone, a mobile application (iOS and Android) with both app-guided and clinician-guided scanning modes, and a web-based Clinician Dashboard for remote image review and patient management. All scans are reviewed by qualified clinicians and can be documented in the patient's EMR. The platform received FDA De Novo marketing authorization in November 2025 and is deployed internationally across the U.S., Europe, Israel, Australia, and Brazil.
Differentiator
Problem solved
Functional benefit
Brands
- Pulsenmore ES: Physician-supervised home prenatal ultrasound solution for remote fetal assessment during pregnancy
- Pulsenmore FC
Products and services
- Pulsenmore ES (Early Screening) FDA-authorized home-use prenatal ultrasound system that includes a handheld smartphone-connected ultrasound device, a mobile application (iOS and Android), and a cloud-based clinician dashboard for remote physician interpretation. Designed for single-fetus pregnancies from week 14 onward and enables both app-guided self-scanning and real-time clinician-guided teleultrasound. Targeted at expectant mothers under physician supervision, OB-GYN and maternal-fetal medicine practices, health systems, and HMOs.
- Pulsenmore FC (Follicular Monitoring) At-home ultrasound solution for remote follicular monitoring in fertility care, enabling IVF and fertility preservation patients to perform transvaginal ultrasound scans at home for monitoring follicle development and endometrial thickness during treatment cycles. Deployed in partnership with fertility clinics and virtual hospitals such as Beilinson NEXT for Clalit Health Services members.
Quantifiable outcome
- 86.3% of surveyed users report a better pregnancy experience
- +4 more outcomes
Companies that use PulseNmore
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
PulseNmore technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
PulseNmore partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, regional, major and strategic.
- Ouma HealthcoreStrategic partnership to integrate PulseNmore's FDA-authorized home ultrasound platform into Ouma Health's virtual maternity care model across the United States. Aims to expand remote prenatal monitoring to underserved patients and expectant mothers facing geographic barriers, including those in maternity deserts. Partnership represents significant expansion into U.S. maternal health market.
- Clalit Health ServicescoreStrategic commercial agreement with Israel's largest HMO (serving ~5 million members) for Pulsenmore FC at-home follicular monitoring for IVF and fertility preservation. Agreement potentially valued at approximately $4.5 million over five years following 18-month pilot. Service deployed via Beilinson NEXT virtual hospital. Also includes Pulsenmore ES home prenatal ultrasound with 25,000 unit agreement over 5 years.
- Beilinson NEXT (Virtual Hospital)coreBeilinson Medical Center's virtual hospital operating PulseNmore FC follicular monitoring service for IVF and fertility preservation patients. Enables eligible patients to perform follicular monitoring scans from home with real-time online guidance and specialist clinical oversight through Beilinson NEXT care team.
- Inteligea Mom to Be Medical ServiceregionalItalian medical assistance service during pregnancy designed for Italian mothers enabling remote fetal monitoring via PulseNmore. First medical assistance service of its kind in Italy, providing constant support from gynecologists, midwives, and doctors 24/7 with PulseNmore-powered remote ultrasound reviews.
- Sheba Medical Center, Tel HashomermajorCommercial agreement for remote monitoring of high-risk pregnancies using home ultrasound solution. Sheba Medical Center utilizes PulseNmore's solution as part of its obstetrics department in 'Sheba Beyond' virtual hospital, offering medical services to insured individuals across various health funds.
- Michigan MedicinestrategicClinical trial collaboration examining ability to conduct remote biophysical profile (BPP) test using PulseNmore home ultrasound with guidance of remote clinician. Study focused on potentially reducing clinical visits while maintaining diagnostic accuracy.
Scale indicators15 records
Recent moves10 records
Expansion highlights6 records
PulseNmore competitors and assessment
Company assessmentDirect peers
- Butterfly Network: Handheld, smartphone-connected ultrasound company offering a single-probe POCUS platform used across multiple clinical specialties. Directly competes with PulseNmore on portable ultrasound form factor and smartphone integration, though Butterfly is not FDA-authorized specifically for home prenatal use.
- Clarius Mobile Health: Handheld, wireless ultrasound scanners that pair with smartphones/tablets. Closest direct comparator to PulseNmore's smartphone-cradle architecture, particularly in OB-GYN and point-of-care obstetrics use cases.
Broad incumbents
- GE HealthCare (Vscan): Global ultrasound incumbent with the Vscan Air handheld family. Also a PulseNmore investor/distributor (potential competitor-investor overlap), making it the most strategically important incumbent shaping the home/portable ultrasound category.
- Philips Lumify: Philips' portable, app-based ultrasound solution for clinicians. A broad incumbent offering overlapping handheld/connected ultrasound capability, though not focused on home prenatal workflows.
- Mindray: Global medical device manufacturer with a broad portable and point-of-care ultrasound portfolio. Operates as a broad incumbent in the same hardware category as PulseNmore across multiple specialties.
- Hologic: Major women's health diagnostics and medical device company with ultrasound and reproductive health offerings. Adjacent incumbent providing diagnostic women's health solutions that overlap with prenatal imaging workflows.
Emerging players
- Exo (Exo Imaging): Developer of handheld ultrasound devices with AI-enabled workflow. Competes with PulseNmore on handheld ultrasound hardware and is pursuing POCUS use cases that overlap with PulseNmore's provider-led model.
- Babyscripts: Virtual maternity care platform providing remote monitoring for pregnant patients. Comparable to PulseNmore on the connected prenatal care delivery model, though focused on software/BPM rather than imaging hardware.
- Maven Clinic: Virtual maternity and family care platform serving employers and health plans. Comparable as a virtual prenatal care delivery model that could partner with or compete against PulseNmore for the same telehealth maternity workflows.
- CooperSurgical: Women's health and fertility device/IVF services company (part of CooperCompanies). Comparable to PulseNmore on the fertility/IVF side, particularly relevant for the Pulsenmore FC follicular monitoring product.
Market position
Weaknesses5 records
Competitive moat5 records
Key risks2 records
Key highlights7 records
Customer concentration
PulseNmore social profiles
Digital presencePulseNmore compliance and trust
Trust signalCompliance8 records
PulseNmore financial estimates
Financial estimateRevenue estimate
Valuation estimate
PulseNmore leadership team
Management profileNumber of profiles
Profiles15 records
PulseNmore subsidiaries and ownership
Company hierarchySubsidiaries1 record
PulseNmore funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PulseNmore M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PulseNmore
What does PulseNmore do?
PulseNmore develops and sells connected home ultrasound hardware devices that pair with a patient's smartphone via a mobile app, enabling expectant mothers to perform guided ultrasound scans at home. The company offers two core products: Pulsenmore ES for prenatal fetal well-being assessment from week 14 and Pulsenmore FC for at-home follicular monitoring in IVF and fertility preservation. Scans are transmitted to a cloud-based clinician dashboard for remote physician interpretation, with a physician-supervised model that includes both app-guided and real-time clinician-guided scanning modes.
Is PulseNmore a public or private company?
PulseNmore is a public company. It is classified as public and is currently operating.
When was PulseNmore founded?
PulseNmore was founded in 2014. It employs 51 to 100 people.
Where is PulseNmore based?
PulseNmore is headquartered in Tel Aviv, Israel, in the Middle East region.
How does PulseNmore make money?
Three revenue lines are on record. Hardware Device Sales are the primary driver. The others are subscription/Service Platform and strategic Investment.
Who are PulseNmore's main competitors?
Direct peers on record are Butterfly Network and Clarius Mobile Health. Broad incumbents are GE HealthCare (Vscan), Philips Lumify, Mindray and Hologic. Emerging players are Exo (Exo Imaging), Babyscripts, Maven Clinic and CooperSurgical.
Does PulseNmore have an API?
No public API is recorded for PulseNmore.
What industry is PulseNmore in?
PulseNmore's product category is Home Prenatal Ultrasound Devices. Its primary akta.pro industry code is HLALAHAC, Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring), with a secondary code of HLACAFAC, Maternal & Neonatal Remote Monitoring Platforms. Its NAICS code is 334510 and its SIC code is 3845.